| | | All patients (N = 150) | ST ≤ 34.98846 (ng/ml) (N = 75) | ST2 > 34.98846 (ng/ml) (N = 75) | value |
| | Age, yrs | 61.63 ± 11.14 | 61.39 ± 10.27 | 61.87 ± 12.02 | 0.79 | | Men | 113 (75.33%) | 55 (73.33%) | 58 (77.33%) | 0.57 | | BMI, kg/m2 | 24.23 ± 3.21 | 24.57 ± 3.08 | 23.88 ± 3.33 | 0.19 | | NYHA function classes | | | | 0.38 | | I and II | 47 (31.33%) | 21 (28.00%) | 26 (34.67%) | — | | III and IV | 103 (68.67%) | 54 (72.00%) | 49 (65.33%) | — | | Hypertension | 53 (35.33%) | 31 (41.33%) | 22 (29.33%) | 0.12 | | Diabetes | 42 (28.00%) | 21 (28.00%) | 21 (28.00%) | 1.00 | | CLBBB | 62 (41.33%) | 39 (52.00%) | 23 (30.67%) | 0.01 | | Ischemic etiology | 70 (46.67%) | 36 (48.00%) | 34 (45.33%) | 0.74 | | Dilated cardiomyopathy | 73 (48.67%) | 37 (49.33%) | 36 (48.00%) | 0.87 | | LA, mm | 44.00 (40.00–49.00) | 43.00 (40.00–48.00) | 45.00 (40.00–51.00) | 0.15 | | LVEDD, mm | 66.00 (62.00–74.00) | 66.00 (62.00–74.00) | 67.00 (62.00–76.00) | 0.82 | | LVEF (%) | 29.41 ± 4.69 | 30.29 ± 4.50 | 28.53 ± 4.74 | 0.02 | | WBC, 109/L | 7.72 ± 2.34 | 7.34 ± 1.81 | 8.10 ± 2.73 | 0.05 | | Device | | | | 0.02 | | ICD | 80 (53.33%) | 33 (44.00%) | 47 (62.67%) | | | CRT-D | 70 (46.67%) | 42 (56.00%) | 28 (37.33%) | | | SCD prevention | | | | 0.003 | | Primary | 110 (73.33%) | 63 (84.00%) | 47 (62.67%) | | | Secondary | 40 (26.67%) | 12 (16.00%) | 28 (37.33%) | | | eGFR, ml/min/1.73 m2 | 78.37 ± 31.95 | 81.08 ± 28.49 | 75.67 ± 35.06 | 0.30 | | HsTNT, ng/ml | 0.03 (0.01–0.05) | 0.02 (0.01–0.05) | 0.03 (0.02–0.05) | 0.88 | | NT-proBNP, pg/ml | 1546.50 (750.20–3119.00) | 1407.00 (673.10–2967.00) | 1844.00 (789.00–4004.00) | 0.10 | | sST2, ng/ml | 34.99 (26.20–47.19) | 26.20 (22.18–31.10) | 47.19 (42.24–62.94) | <0.0001 | | ACEI | 77 (51.33%) | 36 (48.00%) | 41 (54.67%) | 0.41 | | ARB | 34 (22.67%) | 21 (28.00%) | 13 (17.33%) | 0.12 | | β-Blocker | 107 (71.33%) | 50 (66.67%) | 57 (76.00%) | 0.21 | | Uretic | 136 (90.67%) | 68 (90.67%) | 68 (90.67%) | 1.00 |
|
|
Values are mean ± SD, median (interquartile range), or No. (%). BMI, body mass index; NYHA, New York Heart Association; CLBBB, complete left bundle branch block; LVEF, lower left ventricular ejection fraction; CRT-D, cardiac resynchronization defibrillator; ICD, implantable cardioverter defibrillator; SCD, sudden cardiac death; eGFR, estimated glomerular filtration rate; hsTnT, high-sensitivity troponin T; NT-proBNP, terminal protype natriuretic peptide; sST2, soluble suppression of tumorigenesis-2; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.
|
